Data as of Dec 10
| -0.03 / -2.21%|
The 1 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 2.25, with a high estimate of 2.25 and a low estimate of 2.25. The median estimate represents a +69.17% increase from the last price of 1.33.
The current consensus among 1 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.